“…To study the effects of C9ALS DPRs on transport, we used a yeast model expressing 50 repeats of PR or GA, developed by 35 . 50 repeats is lower than common in ALS patients, but similar to previous studies (ranging between 10-65 repeats 35,38,39,48,49,51,55,59,60 ) including a mouse model with 66 repeats which recapitulates molecular and behavioural abnormalities of C9ALS patients 61 . In accordance with previous studies 35–39 , the yeast cells expressing polyPR, but not those expressing polyGA, have a growth defect, as shown by the limited growth in a spot assay (Fig 1A).…”